Vanda Pharmaceuticals Statistics

Total Valuation

LON:0LKB has a market cap or net worth of GBP 198.16 million. The enterprise value is -46.16 million.

Market Cap	198.16M
Enterprise Value	-46.16M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	58.93M
Shares Outstanding	n/a
Shares Change (YoY)	+1.34%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	52.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.27
PB Ratio	0.50
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1.35
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1.01

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.02.

Current Ratio	3.93
Quick Ratio	3.71
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-79.53

Financial Efficiency

Return on equity (ROE) is -8.38% and return on invested capital (ROIC) is -8.42%.

Return on Equity (ROE)	-8.38%
Return on Assets (ROA)	-7.05%
Return on Invested Capital (ROIC)	-8.42%
Return on Capital Employed (ROCE)	-13.72%
Revenue Per Employee	423,488
Profits Per Employee	-93,064
Employee Count	368
Asset Turnover	0.31
Inventory Turnover	6.65

Taxes

Income Tax	-8.81M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-28.53%
50-Day Moving Average	4.33
200-Day Moving Average	4.69
Relative Strength Index (RSI)	55.32
Average Volume (20 Days)	4,707

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.60

Income Statement

In the last 12 months, LON:0LKB had revenue of GBP 155.84 million and -34.25 million in losses. Loss per share was -0.59.

Revenue	155.84M
Gross Profit	147.02M
Operating Income	-56.08M
Pretax Income	-43.05M
Net Income	-34.25M
EBITDA	-49.97M
EBIT	-56.08M
Loss Per Share	-0.59

Full Income Statement

Balance Sheet

The company has 263.86 million in cash and 9.09 million in debt, giving a net cash position of 254.77 million.

Cash & Cash Equivalents	263.86M
Total Debt	9.09M
Net Cash	254.77M
Net Cash Per Share	n/a
Equity (Book Value)	395.83M
Book Value Per Share	6.72
Working Capital	235.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.71 million and capital expenditures -1.89 million, giving a free cash flow of -45.60 million.

Operating Cash Flow	-43.71M
Capital Expenditures	-1.89M
Free Cash Flow	-45.60M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 94.34%, with operating and profit margins of -35.98% and -21.98%.

Gross Margin	94.34%
Operating Margin	-35.98%
Pretax Margin	-27.63%
Profit Margin	-21.98%
EBITDA Margin	-32.06%
EBIT Margin	-35.98%
FCF Margin	n/a

Dividends & Yields

LON:0LKB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.34%
Shareholder Yield	n/a
Earnings Yield	-17.28%
FCF Yield	-23.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0LKB has an Altman Z-Score of 1.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.52
Piotroski F-Score	2